Systemic and organ-specific immune-related manifestations of COVID-19
M Ramos-Casals, P Brito-Zerón… - Nature Reviews …, 2021 - nature.com
Immune-related manifestations are increasingly recognized conditions in patients with
COVID-19, with around 3,000 cases reported worldwide comprising more than 70 different …
COVID-19, with around 3,000 cases reported worldwide comprising more than 70 different …
Acute myocardial infarction after laboratory-confirmed influenza infection
JC Kwong, KL Schwartz, MA Campitelli… - … England Journal of …, 2018 - Mass Medical Soc
Background Acute myocardial infarction can be triggered by acute respiratory infections.
Previous studies have suggested an association between influenza and acute myocardial …
Previous studies have suggested an association between influenza and acute myocardial …
[HTML][HTML] Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance
H Wang, R Li, Z Zhou, H Jiang, Z Yan, X Tao… - Journal of …, 2021 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19) induces myocardial injury,
either direct myocarditis or indirect injury due to systemic inflammatory response. Myocardial …
either direct myocarditis or indirect injury due to systemic inflammatory response. Myocardial …
SARS-CoV-2 leads to a small vessel endotheliitis in the heart
Abstract Background SARS-CoV-2 infection (COVID-19 disease) can induce systemic
vascular involvement contributing to morbidity and mortality. SARS-CoV-2 targets epithelial …
vascular involvement contributing to morbidity and mortality. SARS-CoV-2 targets epithelial …
[HTML][HTML] The incidence of myocarditis and pericarditis in post COVID-19 unvaccinated patients—a large population-based study
O Tuvali, S Tshori, E Derazne, RR Hannuna… - Journal of clinical …, 2022 - mdpi.com
Myocarditis and pericarditis are potential post-acute cardiac sequelae of COVID-19
infection, arising from adaptive immune responses. We aimed to study the incidence of post …
infection, arising from adaptive immune responses. We aimed to study the incidence of post …
[HTML][HTML] Cardiac troponin-I and COVID-19: a prognostic tool for in-hospital mortality
BAL Abbasi, P Torres, F Ramos-Tuarez… - Cardiology …, 2020 - ncbi.nlm.nih.gov
Background The number of fatalities due to coronavirus disease 2019 (COVID-19) is
escalating with more than 800,000 deaths globally. The scientific community remains in …
escalating with more than 800,000 deaths globally. The scientific community remains in …
[HTML][HTML] Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis
Abstract Background Coronavirus disease 2019 (COVID-19) has been reported to cause
worse outcomes in patients with underlying cardiovascular disease, especially in patients …
worse outcomes in patients with underlying cardiovascular disease, especially in patients …
Myocardial work efficiency, a novel measure of myocardial dysfunction, is reduced in COVID-19 patients and associated with in-hospital mortality
AS Minhas, NA Gilotra, E Goerlich, T Metkus… - Frontiers in …, 2021 - frontiersin.org
Background: Although troponin elevation is common in COVID-19, the extent of myocardial
dysfunction and its contributors to dysfunction are less well-characterized. We aimed to …
dysfunction and its contributors to dysfunction are less well-characterized. We aimed to …
Veno-venous extracorporeal membrane oxygenation allocation in the COVID-19 pandemic
Rapid global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
the resultant clinical illness, coronavirus disease 2019 (COVID-19), drove the World Health …
the resultant clinical illness, coronavirus disease 2019 (COVID-19), drove the World Health …